search
Back to results

Standardizing Right Hemicolectomy for Colon Cancer (Right)

Primary Purpose

Colonic Carcinoma, Laparoscopic Right Hemicolectomy, Standardisation

Status
Not yet recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Implementation standardised laparoscopic right hemicolectomy with proctoring
Implementation standardised laparoscopic right hemicolectomy without proctoring
Sponsored by
Amsterdam UMC, location VUmc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colonic Carcinoma

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Planned laparoscopic (extended) right hemicolectomy for colon cancer of the caecum, ascending colon or hepatic flexure;
  • Age above 18 years;
  • cTNM stage 1-3 (CT-staged);
  • No prior midline or transverse laparotomy;
  • ASA1-3;
  • No immune modulating medication.

Exclusion Criteria:

  • cT4b;
  • Perforated disease;
  • Acute obstruction;
  • Emergency operation;
  • Appendiceal cancer;
  • Other primary malignancy treated within 5 years from diagnosis of colon cancer, except for curatively treated prostate, breast, skin and cervical cancer.

Sites / Locations

  • Amsterdam UMC, location VUmc

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Active Comparator

Active Comparator

Arm Label

Surgical variations laparoscopic right hemicolectomy

Implementing standardised laparoscopic right hemicolectomy with proctoring

Implementing standardised laparoscopic right hemicolectomy without proctoring

Arm Description

Outcomes

Primary Outcome Measures

30-day morbidity with Clavien-Dindo grading

Secondary Outcome Measures

Intraoperative complications (i.e. vascular injury)
Conversion rate from laparoscopic to open surgery
Operative time
Blood loss
Validated assessment of plane of dissection
Assessment according to a competency assessment tool (CAT) for laparoscopic right hemicolectomy. This tool will be created during phase 2 using the Delphi method.
Validated assessment of level of vascular ligation
Assessment according to a competency assessment tool (CAT) for laparoscopic right hemicolectomy. This tool will be created during phase 2 using the Delphi method.
Grading of the resection specimen according to Benz et al. 2019
Total lymph node count
Number of resected positive lymph nodes
Resection margins
Radicality of resection margin of the specimen, as assessed by the pathologist.
Completeness of mesocolic excision based on postoperative CT imaging
Locoregional recurrence
Distant metastasis
3-year disease free survival (DFS)
5-year overall survival (OS)
Long term morbidity: incisional hernia, adhesion related small bowel obstruction, readmissions, reinterventions

Full Information

First Posted
April 30, 2021
Last Updated
May 13, 2021
Sponsor
Amsterdam UMC, location VUmc
Collaborators
Prof. dr. P.J. Tanis, colorectal surgeon, Dr. B.R. Toorenvliet, colorectal surgeon, D. Miskovic, St Marks hospital London, UK, S. Benz, Klinikverbund SuedWest, Böblingen, Germany, F. Aigner, Krankenhaus der Barmherzigen Bruder, Graz, Austria, C.A. Bertelsen, Hillerød University Hospital, Copenhagen, Denmark, Drs. A.A.J. Grüter, Dr. U.K. Coblijn, Dr. H.L. van Westreenen, Dr. C. Sietses, Prof. dr. E.C.J. Consten, Dr. A.W.H. van de Ven, Dr. P. van Duijvendijk, Dr. S. van Aalten, Dr. F. den Boer, Dr. J.W.A. Leijtens, Dr. C. Hoff, Dr. O. van Ruler, Dr. G. D. Slooter, Prof. dr. J. Lange, Prof. dr. G.J. Kleinrensink
search

1. Study Identification

Unique Protocol Identification Number
NCT04889456
Brief Title
Standardizing Right Hemicolectomy for Colon Cancer
Acronym
Right
Official Title
Implementation of Optimized and Standardized Surgical Technique for Right Sided Colon Cancer: a Prospective Interventional Sequential Cohort Study With a Transition Period
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2021 (Anticipated)
Primary Completion Date
July 1, 2022 (Anticipated)
Study Completion Date
July 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Amsterdam UMC, location VUmc
Collaborators
Prof. dr. P.J. Tanis, colorectal surgeon, Dr. B.R. Toorenvliet, colorectal surgeon, D. Miskovic, St Marks hospital London, UK, S. Benz, Klinikverbund SuedWest, Böblingen, Germany, F. Aigner, Krankenhaus der Barmherzigen Bruder, Graz, Austria, C.A. Bertelsen, Hillerød University Hospital, Copenhagen, Denmark, Drs. A.A.J. Grüter, Dr. U.K. Coblijn, Dr. H.L. van Westreenen, Dr. C. Sietses, Prof. dr. E.C.J. Consten, Dr. A.W.H. van de Ven, Dr. P. van Duijvendijk, Dr. S. van Aalten, Dr. F. den Boer, Dr. J.W.A. Leijtens, Dr. C. Hoff, Dr. O. van Ruler, Dr. G. D. Slooter, Prof. dr. J. Lange, Prof. dr. G.J. Kleinrensink

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A surgical intervention might be highly variable amongst surgeons and centers. This variability has a potential relevance concerning clinical outcomes. For right-sided colon cancer, the laparoscopic right hemicolectomy (LRHC) knows substantial variation. Especially since the surgical technique has been evolving during the latest decade with the introduction of intracorporeal anastomosis, a dissection technique within the correct embryological planes (complete mesocolic excision) and central vascular ligation of the segmental branches at its origin, resulting in an optimal lymph node dissection. Given the insights from recent studies showing the association between quality of surgery and relevant clinical outcomes, there is a great need for a formative quality assessment of LRHC. Detailed objective assessment of the LRHC is currently not performed in clinical practice nor in surgical training. Quality assessment of LRHC has great potential to improve surgical training and furthermore, implementation of a standardized technique will ultimately lead to better quality of care for patients suffering from right-sided colon cancer. The main objective of this study is to improve surgical outcomes for patient with right-sided colon cancer by a prospective sequential interventional cohort study that aims to standardize the surgical technique with subsequent controlled implementation after standardized review of the current practice in a nationwide multicenter setting. The primary endpoint is the 30-day morbidity according to the Clavien-Dindo classification system.
Detailed Description
Prospective mapping of current practice with surgical variations in laparoscopic right hemicolectomy (total duration of inclusion 3 months) N= 40 centers N = 310 videos METC approval for the use of anonymized videos of a laparoscopic procedure and collection of corresponding clinical outcomes. Approaching hospitals for participation (high volume centers (50+ colon cancers). Prospective inclusion of consecutive patients undergoing laparoscopic right hemicolectomy in the participating hospitals in three months. Development of Standard Laparoscopic Right Hemicolectomy: an (inter)national Delphi study Approaching specialists to participate in the Delphi method (from participating hospitals in step 1). Identification of crucial steps and measures according to literature and expert's opinion (Delphi method). Documentation of steps and the order in which they need to be performed, development of a competency assessment tool (CAT). Skills center training facility a. Training the participating surgeons in the method of the standardized laparoscopic right hemicolectomy, as consented in the Delphi method. Implementation of the standardized laparoscopic right hemicolectomy with proctoring during another period with prospective inclusion of consecutive patients with collection of surgical videos in all participating hospitals (N=40 centers, total 310 videos) Rating videos. Comparing with pre-implementation performance based on outcome measures reflecting oncological quality of surgery, and 30-day clinical outcomes. Comparing with pre-implementation performance based on the long-term outcomes. (3-year DFS and 5-year OS). Implementing standardised lap right hemicolectomy (after learning curve without proctoring) Consecutive inclusion of patients (n=310) CT imaging Video analysis Competency analysis Variation analysis Clinico pathological data

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colonic Carcinoma, Laparoscopic Right Hemicolectomy, Standardisation, Training, Delphi Study, Implementation, Consolidation, Assessment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
A prospective interventional sequential cohort study with a transition period
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
930 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Surgical variations laparoscopic right hemicolectomy
Arm Type
No Intervention
Arm Title
Implementing standardised laparoscopic right hemicolectomy with proctoring
Arm Type
Active Comparator
Arm Title
Implementing standardised laparoscopic right hemicolectomy without proctoring
Arm Type
Active Comparator
Intervention Type
Procedure
Intervention Name(s)
Implementation standardised laparoscopic right hemicolectomy with proctoring
Intervention Description
Implementation standardised laparoscopic right hemicolectomy with proctoring
Intervention Type
Procedure
Intervention Name(s)
Implementation standardised laparoscopic right hemicolectomy without proctoring
Intervention Description
Implementation standardised laparoscopic right hemicolectomy without proctoring
Primary Outcome Measure Information:
Title
30-day morbidity with Clavien-Dindo grading
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Intraoperative complications (i.e. vascular injury)
Time Frame
1 day
Title
Conversion rate from laparoscopic to open surgery
Time Frame
1 day
Title
Operative time
Time Frame
1 day
Title
Blood loss
Time Frame
1 day
Title
Validated assessment of plane of dissection
Description
Assessment according to a competency assessment tool (CAT) for laparoscopic right hemicolectomy. This tool will be created during phase 2 using the Delphi method.
Time Frame
1 day
Title
Validated assessment of level of vascular ligation
Description
Assessment according to a competency assessment tool (CAT) for laparoscopic right hemicolectomy. This tool will be created during phase 2 using the Delphi method.
Time Frame
1 day
Title
Grading of the resection specimen according to Benz et al. 2019
Time Frame
1 day
Title
Total lymph node count
Time Frame
1 day
Title
Number of resected positive lymph nodes
Time Frame
1 day
Title
Resection margins
Description
Radicality of resection margin of the specimen, as assessed by the pathologist.
Time Frame
1 day
Title
Completeness of mesocolic excision based on postoperative CT imaging
Time Frame
1 day
Title
Locoregional recurrence
Time Frame
3 years
Title
Distant metastasis
Time Frame
3 years
Title
3-year disease free survival (DFS)
Time Frame
3 years
Title
5-year overall survival (OS)
Time Frame
5 years
Title
Long term morbidity: incisional hernia, adhesion related small bowel obstruction, readmissions, reinterventions
Time Frame
3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Planned laparoscopic (extended) right hemicolectomy for colon cancer of the caecum, ascending colon or hepatic flexure; Age above 18 years; cTNM stage 1-3 (CT-staged); No prior midline or transverse laparotomy; ASA1-3; No immune modulating medication. Exclusion Criteria: cT4b; Perforated disease; Acute obstruction; Emergency operation; Appendiceal cancer; Other primary malignancy treated within 5 years from diagnosis of colon cancer, except for curatively treated prostate, breast, skin and cervical cancer.
Facility Information:
Facility Name
Amsterdam UMC, location VUmc
City
Amsterdam
State/Province
Noord-Holland
ZIP/Postal Code
1081 HV
Country
Netherlands
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexander A.J. Grüter, MD
Phone
+316 45552015
Email
alexandergruter@hotmail.com
First Name & Middle Initial & Last Name & Degree
Usha K. Coblijn, MD, PhD
Phone
+316 43469794
Email
usha.coblijn@gmail.com
First Name & Middle Initial & Last Name & Degree
Jurriaan B. Tuynman, MD, PhD
First Name & Middle Initial & Last Name & Degree
Pieter J. Tanis, MD, PhD, Prof
First Name & Middle Initial & Last Name & Degree
Boudewijn R. Toorenvliet, MD, PhD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Standardizing Right Hemicolectomy for Colon Cancer

We'll reach out to this number within 24 hrs